Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Japan Insulin Pen Market Growth Outlook 2025-2033" has been added to ResearchAndMarkets.com's offering. The Japan Insulin Pen Market is forecasted to ...

India faces a diabetes crisis with 101 million affected, yet insulin use is hampered by myths. Experts urge timely insulin ...

Growth is driven by increasing demand for personalized treatment, improved delivery technologies, and biosimilars, despite challenges like high costs and regulatory demands Rapid Acting Insulin Market ...

The global injection pen market is expected to grow at a rate of 7% over the next five years. Key factors fueling this growth include the rising prevalence of chronic diseases, the increasing demand ...

The EMA’s CHMP has endorsed Ondibta for diabetes and Osqay for osteoporosis, a move that could broaden access to effective, ...

Scientists have discovered that human stomach cells can be genetically reprogrammed to act like pancreatic beta cells and ...

An international study co-led by University of Calgary researchers has found new insulin delivery technology helps control ...

Over one-third of Americans are prediabetic or have full-blown diabetes. Too many don't know they have it, ignore the problem ...

The state’s CalRx Insulin Glargine will be available to consumers for a suggested retail price of $55 or less per five-pack of pens beginning Jan. 1, 2026. The insulin glargine pen agreement with ...

Expanded Partnership Will Increase Access to Diabetes Care for Communities Across the U.S. and GloballyPARSIPPANY, N.J., Nov.

Globally, around 20 million people live with type 1 diabetes, including 1.1 million children and young adults under 20. In ...